Brabant G, Brennecke I, Herrmann H, Friedrich H, Wagner T O, von zur Mühlen A, Hesch R D
Dtsch Med Wochenschr. 1985 Oct 11;110(41):1564-7. doi: 10.1055/s-2008-1069047.
185 patients with hyperprolactinaemia and prolactinoma were evaluated in a retrospective investigation. 128 patients were treated surgically whereby the prolactin serum level in 47% of the macroprolactinoma and 60% of the microprolactinoma patients was normalised (prolactin less than 25 ng/ml, no radiological evidence of tumor). Of those patients in whom the operation was less successful, a normal prolactin level could be achieved in 77% by additional therapy with dopamine agonists. Of 57 patients handled exclusively with drugs, the prolactin level was normalised by dopamine agonists in 78%. A small number of patients from both groups did not show a satisfactory fall in the prolactin level despite the use of markedly higher doses of dopamine agonists. During dopamine agonist therapy progressive tumor enlargement was detected radiologically in a previously operated patient.
在一项回顾性研究中,对185例高泌乳素血症和泌乳素瘤患者进行了评估。128例患者接受了手术治疗,其中47%的大泌乳素瘤患者和60%的微泌乳素瘤患者的血清泌乳素水平恢复正常(泌乳素低于25 ng/ml,无肿瘤的影像学证据)。在手术效果欠佳的患者中,通过额外使用多巴胺激动剂治疗,77%的患者泌乳素水平恢复正常。在仅接受药物治疗的57例患者中,78%的患者通过多巴胺激动剂使泌乳素水平恢复正常。尽管使用了明显更高剂量的多巴胺激动剂,但两组中仍有少数患者的泌乳素水平未出现令人满意的下降。在多巴胺激动剂治疗期间,一名曾接受手术的患者经影像学检查发现肿瘤进行性增大。